View Older Stories View More Recent Stories

May 20, 2020 05:23PM Form 13F-HR/A venBio Partners LLC For: Sep 30
May 20, 2020 05:22PM Form 13F-HR/A venBio Partners LLC For: Mar 31
May 20, 2020 05:22PM Form 13F-HR/A venBio Partners LLC For: Jun 30
May 15, 2020 04:20PM Form 13F-HR venBio Partners LLC For: Mar 31
May 6, 2020 04:01PM PPD Reports First Quarter 2020 Results
Apr 16, 2020 12:47PM Form SC 13D/A Menlo Therapeutics Inc. Filed by: venBio Global Strategic Fund II L.P.
Apr 3, 2020 08:00AM venBio Closes $394 Million Life Sciences Venture Capital Fund
Mar 26, 2020 05:22PM Form D/A venBio Global Strategic
Mar 4, 2020 04:01PM PPD Reports Fourth Quarter and Full Year 2019 Results
Mar 3, 2020 05:53PM Form 4 Akero Therapeutics, Inc. For: Feb 28 Filed by: venBio Global Strategic GP II, L.P.
Feb 13, 2020 02:27PM Form 13F-HR venBio Partners LLC For: Dec 31
Feb 12, 2020 07:00AM ALX Oncology Announces Closing of $105 Million Series C Financing
Feb 10, 2020 05:48PM Form 4 Akero Therapeutics, Inc. For: Feb 06 Filed by: venBio Global Strategic GP II, L.P.
Jan 15, 2020 04:27PM Form SC 13D/A Akero Therapeutics, Inc. Filed by: venBio Global Strategic Fund II L.P.
Jan 8, 2020 03:00AM NorthSea Therapeutics Announces US $40 Million Series B Financing to Complete Phase IIb ICONA study in NASH and to Advance Two Additional SEFAs into the Clinic
Jan 6, 2020 04:08PM Form 4 Akero Therapeutics, Inc. For: Jan 02 Filed by: venBio Global Strategic GP II, L.P.
Nov 14, 2019 12:43PM Form 13F-HR venBio Partners LLC For: Sep 30
Oct 8, 2019 12:37PM Swift Health Systems Raises $45 Million in Series C Funding
Oct 4, 2019 01:40AM Evotec Reaches Milestone In Integrated Drug Discovery And Development Partnership With Aeovian
Oct 3, 2019 08:00AM Aeovian Pharmaceuticals Raises $37 Million Series A Financing to Advance Selective mTORC1 Inhibitors into the Clinic for Rare and Age-Related Diseases
Sep 10, 2019 07:00AM Pharvaris Announces $66 Million Series B Financing to Advance the Clinical Development of an Oral Therapy for Hereditary Angioedema
Aug 14, 2019 10:28AM Form 13F-HR venBio Partners LLC For: Jun 30
Aug 7, 2019 06:00AM Athenex, Inc. Announces Second Quarter 2019 Financial Results, Positive Phase III Results on Oral Paclitaxel plus Encequidar and Increased Product Sales Guidance
Aug 7, 2019 06:00AM Athenex, Inc. Announces Second Quarter 2019 Financial Results, Positive Phase III Results on Oral Paclitaxel plus Encequidar and Increased Product Sales Guidance
Jun 26, 2019 04:20PM Form SC 13D Akero Therapeutics, Inc. Filed by: venBio Global Strategic Fund II L.P.
Jun 25, 2019 09:21AM Form 4 Akero Therapeutics, Inc. For: Jun 24 Filed by: venBio Global Strategic GP II, Ltd.
May 15, 2019 11:53AM Form 13F-HR venBio Partners LLC For: Mar 31
May 9, 2019 07:00AM Athenex, Inc. Announces First Quarter 2019 Financial Results and Provides Corporate Update
May 9, 2019 07:00AM Athenex, Inc. Announces First Quarter 2019 Financial Results and Provides Corporate Update
May 6, 2019 08:11AM Athenex (ATNX) Announces $100 Million Private Placement of Common Stock
May 6, 2019 08:00AM Athenex Announces $100 Million Private Placement
May 6, 2019 08:00AM Athenex Announces $100 Million Private Placement
Apr 18, 2019 07:00AM Arrakis Therapeutics Announces $75 Million Series B Financing to Advance a New Class of Small-Molecule Medicines Targeting RNA
Apr 9, 2019 05:18PM Form SC 13D PRECISION BIOSCIENCES Filed by: venBio Global Strategic Fund, L.P.
Apr 1, 2019 05:36PM Form 4 PRECISION BIOSCIENCES For: Apr 01 Filed by: venBio Global Strategic GP, L.P.
Mar 26, 2019 09:20AM Form D/A venBio Global Strategic
Mar 20, 2019 04:06PM Form 4 Mirati Therapeutics, For: Mar 18 Filed by: venBio Select Advisor LLC
Mar 11, 2019 07:00AM Precision BioSciences Enters Into Private Convertible Note Financing
Feb 21, 2019 04:13PM Form 4 Mirati Therapeutics, For: Feb 20 Filed by: venBio Select Advisor LLC
Feb 14, 2019 01:36PM Form 13F-HR venBio Partners L.P. For: Dec 31
Feb 14, 2019 11:12AM Form 13F-HR venBio Select Advisor For: Dec 31
Feb 14, 2019 10:04AM Form SC 13G/A ALIMERA SCIENCES INC Filed by: venBio Select Advisor LLC
Feb 14, 2019 08:51AM Form SC 13G/A Apellis Pharmaceuticals, Filed by: venBio Global Strategic Fund II L.P.
Feb 14, 2019 08:50AM Form SC 13G/A Nabriva Therapeutics Filed by: venBio Global Strategic Fund II L.P.
Feb 14, 2019 08:45AM Form SC 13G/A Teligent, Inc. Filed by: venBio Select Advisor LLC
Feb 14, 2019 08:37AM Form SC 13G Xenon Pharmaceuticals Filed by: venBio Select Advisor LLC
Feb 14, 2019 08:34AM Form SC 13G/A IOVANCE BIOTHERAPEUTICS, Filed by: venBio Select Advisor LLC
Feb 14, 2019 08:33AM Form SC 13G/A FENNEC PHARMACEUTICALS Filed by: venBio Select Advisor LLC
Feb 14, 2019 08:29AM Form SC 13G/A Intec Pharma Ltd. Filed by: venBio Select Advisor LLC
Feb 14, 2019 08:25AM Form SC 13G/A AMICUS THERAPEUTICS, Filed by: venBio Select Advisor LLC
View More Recent Stories View Older Stories